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ABSTRACT: Allergic diseases are important concern of 
public health. A reliable diagnosis is of utmost importance 
for the management of allergic patients both when 
immunotherapy is planned and when the treatment is 
essentially based on the avoidance of the allergy source. 
However, the available diagnostic systems sometimes fail to 
detect specific IgE antibodies thus impairing the correct 
diagnosis. The traditional test systems are generally based on 
the use of protein extracts derived from the allergenic 
sources whose composition is very variable and cannot be 
standardized. The development of a new methodology 
combining the so-called allergenic molecule-based diagnosis 
with the multiplex microarray technology and allowing the 
analysis of multiple purified allergens in a single test 
represents an important improvement in allergy diagnosis. 
In addition, the biochemical and immunological 
characterisation of individual allergens has provided new 
insights into the understanding of allergen-IgE recognition 
that could be exploited for further improvements of allergy 
diagnostic tests. 
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INTRODUCTION 
The prevalence of allergic diseases, affecting both 
children and adults, is reported to be on the rise and these 
pathologies are no longer confined to specific seasons, or 
to people living in specific areas [1-5]. It has been 
estimated that 25% of the population worldwide suffer 
from this problem, and within this number 1-2% of adults 
and 5-7% of children suffer from food allergies [6]. The 
causes of the epidemic spread of reported allergies are still 
unclear and may be due to a combination of different 
factors. Various hypotheses have been made associating 
such an increase to an increased hygiene levels (the so-
called ‘‘hygiene hypothesis’), to a genetic proneness, to 
the increasing use of products deriving from industrial 
food-processing and to other unknown reasons [5,7-10].  
The effect of globalization is also included in the list 
of causes that seem to play a key role in the spread of 
allergic reactions. In fact, not only populations migrate but 
also foods. A classic example is the allergy to kiwifruit. 
Some decades ago, this allergy was absent in geographical 
areas such as Europe and USA because no one ever ate 
kiwifruit at that time. Now many people eat this fruit and 
lots of kiwifruit allergies have been described [11]. These 
aspects may strongly affect the widespread proliferation of 
food allergies. 
It is actually very difficult to have exact 
epidemiological data on this topic. In addition, a 
discrepancy between the rates of perceived food allergy 
and the rates of true allergy has been observed. In fact, 
literature reports state that people have a perception of 
food allergy even four times higher than that confirmed by 
available allergy tests [11]. A possible explanation is that 
people sometimes confuse allergy with intolerance (due to 
metabolic conditions, such as lactose intolerance, or other 
immunological mechanisms as in coeliac disease) or with 
mild food poisoning [12-13]. Some discrepancies could 
also be due to some false results provided by the available 
diagnostic systems. In fact, depending on the methodology 
and reagents used, in vitro serological tests (RAST, 
ImmunoCAP) and in vivo tests (skin prick test (SPT), 
prick-by-prick test) sometimes can provide false negative 
responses [14]. In some cases, it seems that the only way 
to assess the allergy to a food is by feeding/challenging 
the patient with the suspected food. However, this practice 
is risky mostly when applied to subjects reporting severe 
allergic reactions. Therefore, to obtain a reliable and safe 
diagnosis it seems mandatory to improve in vitro or ex 
vivo allergy diagnostic systems [15]. 
THE ALLERGIC REACTION 
An allergic reaction is an abnormal response of the 
human body when in contact with an allergen. The most 
common allergen sources of protein nature include house 
dust mite, pollens from grasses, weeds and trees, animal 
dander (including cat, dog and horse), moulds, foods 
(including tree nuts, peanuts, shellfish, fish, milk, eggs, 
wheat, fruits), hymenoptera venoms, and latex. When a 
sensitive subject is exposed to the allergy source a type of 
white blood cells (B lymphocytes) produce a specific 
antibody known as Immunoglobulin E (IgE) against the 
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allergenic molecule(s) contained in that stuff (primary 
response or sensitization). The IgE then binds to another 
type of white blood cell (mast cells) by mean of a specific 
high affinity receptor (FCεR), and when the mast cells 
come into contact with that allergen(s) again, they initiate 
a complex immune response, involving the release of 
preformed or neo-formed inflammation mediators, that 
cause the allergy symptoms (Figure 1). The allergic 
reaction may cause one or more symptoms that may be 
more or less severe, including urticaria, rhinitis, 
conjunctivitis, angioedema, oral allergic syndrome, 
abdominal pain, diarrhea, asthma, anaphylactic shock. 
Mainly for those people showing severe symptoms, it is 
important to be able to correctly identify the allergenic 
sources to which the patient reacts.  
 
Fig.  1.  Release of inflammatory mediators from IgE-sensitized mast 
cells after interaction with allergens. 
DIAGNOSIS: ALLERGIC, OR NOT ALLERGIC, THIS 
IS THE QUESTION 
The traditional testing systems are generally based on 
the use of commercially available protein extracts derived 
from the allergenic sources. However, they frequently fail 
to detect specific IgE because their composition can be 
very variable. Ripening stage, post-harvest treatments, 
differences among cultivars, proteolytic degradation and 
protocols used for the extraction significantly affect the 
relative amounts of many proteins and the profile of 
allergenic components [16-18]. 
Since it seems impossible to obtain standardized 
extracts with a constant allergenic composition and 
containing all the allergenic proteins present in the natural 
source, molecule-based diagnosis has gained more 
attention in the recent past. In fact, the scientific research 
and the companies are evolving through the development 
of new technologies useful for the detection of specific 
IgE against individual allergenic molecules. Unlike 
traditional systems, these won't use protein extracts, but 
only natural or recombinant purified allergens, that in this 
way will allow a better standardization of the whole 
system.  
The multiplex microarray-based technology of the “ISAC 
system”: a new methodology 
ISAC (Immuno Solid-phase Allergen Chip) is an in 
vitro diagnostic system useful for semiquantitative 
analysis of IgE in serum samples [19-22]. In contrast with 
the traditional systems, it uses only purified allergens. It is 
made of a microscope glass slide containing four identical 
reaction chambers (Figure 2A) and each chamber is a 
microarray where individual allergens are immobilized 
separately (Figure 2B). The IgE contained in the serum of 
an allergic subject recognize one or more immobilized 
allergens on the microarray (Figure 2C) and the 
interaction is revealed using a secondary antibody labeled 
with a fluorescent probe, specific for human IgE (Figure 
2D).  
 
Fig. 2. ISAC system. A, chip with 4 reaction chambers. B, purified 
allergens spotted on the microarray. C, IgE-allergen interaction is 
revealed by a fluorescent dye conjugated with an anti-IgE antibody; the 
allergenic proteins immobilized on the chip are in blue, the human IgE 
are in red and the anti-IgE are in yellow. D, the fluorescence intensity is 
measured using a “microarray scanner”. 
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This multiplex microarray-based technology allows 
the simultaneous measurement of IgE antibodies specific 
for different individual allergens (i.e. multiplex analysis) 
with the same serum sample [21-23]. Therefore it can be 
exploited to perform some steps of the classic procedures 
easier and faster. In some allergy centers, it is routinely 
used for allergy diagnosis providing information on the 
subjects’ sensitisation to all the allergens available on the 
microarray with a single test [21-22,24-25].  
Few years ago the first version of the ISAC 
microarray became commercially available. It had 74 
different allergenic proteins spotted on the microarray 
(ISAC74). The number of allergens immobilized on this 
microarray is growing and at present a version with 112 
allergens (ISAC112) is available. 
There are other diagnostic systems (i.e. ImmunoCAP, 
Immulite) that recently started to use allergenic molecules, 
that is the purified allergens rather than the raw extracts, 
for allergy diagnosis. However, they can analyze only one 
allergen for each test (IgE singleplex testing). 
The ISAC system, providing IgE multiplex testing, 
adds important advantages to the singleplex testing. For 
instance,  the  ISAC  system is  a  time-saving and money- 
saving methodology because information about many 
allergens is obtained with a single test. An additional 
advantage is the possibility to detect the IgE reactivity 
towards hidden or unsuspected allergens/allergy sources. 
In fact, sometimes the allergic reaction can be caused by a 
contamination of foods that can contain unexpected 
components. For instance, if a subject reports the 
appearance of allergic symptoms after the ingestion of 
chicken and after the ingestion of fish, the allergologist 
that uses the singleplex test systems will test the reactivity 
to chicken and to fish.  
If the response of the testing is negative, then the 
allergy trigger will remain a mistery and the subject will 
exclude chicken and fish from his/her diet (Figure 3). In 
contrast, if the allergologist uses a multiplex system the 
response could reveal the presence in the subject’s serum 
of IgE specific for components of unsuspected allergy 
sources, such as spices or, for example, for the fish 
parasite Anisakis simplex, whose allergenic components 
have been detected even in chicken fed with seafood 
infested by it [26]. Therefore, the multiplex system can 
reveal sensitisation sources even when the patient does not 
or cannot report indications about the allergy triggers [21].  
 
Fig. 3. Example of the possible hidden origin of an allergic reaction. 
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Does one allergen fit all the homologs? …be careful! 
Some allergens are widely distributed in 
taxonomically different organisms [27]. For instance, 
important plant food allergens, such as the Lipid Transfer 
Proteins (LTP), are quite ubiquitous proteins. It means 
that homologs of LTP can be present in many, if not all, 
botanically different plant-derived foods.  
Up to now LTP from 63 different plant sources have 
been reported as allergens (www.allergome.org) [28], 46 
of them are present in edible parts of plants and all of 
them belong to the LTP1 protein subfamily. Among 
allergenic LTPs, the best characterized at the structural, 
immunological and clinical level is the peach LTP, Pru p 3 
(Figure 4).  
 
Fig. 4. Molecular structure of the allergenic peach LTP1, Pru p 3. 
LTP is a small allergen (9 kDa) that can cause severe 
symptoms, including the anaphylactic shock, and one of 
the most important sensitizer in the Mediterranean area 
[29-32]. In allergy diagnosis, there is the trend to use the 
peach LTP, Pru p 3, to assess allergy to all the plant LTP. 
This could be a reasonable procedure if all homologous 
LTPs had identical epitopes recognized by IgE. 
Unfortunately, this seems not to be the case, otherwise a 
subject allergic to LTP should react and avoid any plant-
derived food. Several reviews on the topic of LTP 
reported preliminary evidence of a heterogeneous 
immunological behaviour of this group of molecules [33-
34]. A recent paper reported a comparative study of peach 
and kiwifruit LTPs showing by in vitro and in vivo tests 
that some subjects were IgE positive to some LTPs and 
negative to some others [35]. In this study, in addition to 
subjects showing positive reaction to both peach and 
kiwifruit LTP, few subjects reacted only to LTP from one 
fruit and did not react to the other. The results obtained by 
in vivo tests on allergic subjects could be ascribed to the 
heterogeneous epitope pattern present in the different 
LTPs. These results underline that the concept “one 
allergen fits all the homologs”, that is sometimes applied 
[36-38], may produce some erroneous diagnosis. The 
comparative study of kiwifruit and peach LTPs [35] 
clearly indicates that the biochemical grouping of 
allergens can be misleading in the allergy diagnosis and 
that an improvement can be obtained by testing every 
single patient with the most comprehensive panel of 
available LTPs/allergens. The observation that some 
subjects have isolated IgE positivity to single 
LTP/allergens provides useful information on what to 
exclude but, most importantly, on what to leave in 
patient’s diet. 
Allergens are proteins…don’t forget it! 
Allergens have a protein nature, therefore they have 
all the properties of protein molecules. It is well-known 
that the protein structure and function is strongly affected 
by the chemical and physical features of the environment, 
including the chemical composition of the medium, ionic 
strenght, pH, temperature, etc. The function of some 
proteins is implemented by the interaction with another 
protein molecule. This protein-protein interaction can 
occurr or not, it depends on the 
environmental/experimental conditions around the two 
actors.  
Allergy diagnosis is based on the detection of a 
protein-protein interaction, involving the allergen and the 
IgE antibody specifically recognizing the allergen under 
investigation. The available diagnostic systems apply the 
same experimental condition (phosphate buffered saline at 
neutral pH) to evaluate the sensitivity to any allergen, 
independently of the characteristics of the allergy source 
or the environment that an allergen can encounter during, 
for example, the transit through the gastrointestinal tract.  
Recently, a study focused on kiwellin (allergen Act d 
5 [39]) has shown that the number of subjects showing a 
positive in vivo test (SPT) to this kiwifruit allergen was 
increased when, in addition to the standard protocol, 
conditions more similar to those present in kiwifruit were 
used to solubilize the allergen [40]. The observation that 
some subjects had a positive reaction either at neutral or 
acidic pH values suggests that this allergen, depending on 
the environmental conditions, may expose different 
epitopes. Nevertheless, some subjects may have IgE 
antibodies recognizing epitopes exposed in each of the 
two investigated environmental conditions. The 
conformational analysis by circular dichroism 
measurements in different experimental conditions 
indicate that Act d 5 3D structure is modulated by the 
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solvent pH and polarity [40]. Therefore, Act d 5 displays 
pH-driven conformational changes, but this effect is more 
evident in a low-dielectric costant medium, that is 
representative of several cellular environments [41], like 
for instance the interior of biological membranes. During 
the transit in the gastrointestinal system, Act d 5 can 
encounter environments characterized by different pH 
values, ranging from the very acidic one of the stomach to 
values close to neutrality, and can meet the hydrophobic 
environments of the cell membranes. Therefore, it may be 
hypothesized that, depending on the environments 
encountered, this allergen may undergo in vivo 
conformational changes and expose different epitopes, 




Although in some cases the immunotherapy can be 
suggested, the best treatment of allergic subjects is still 
based on the avoidance of the allergen source. In the case 
of a food allergy, it means the exclusion of specific foods 
from the diet. The implication is that a proper 
management of these subjects requires a highly reliable 
diagnosis in order to identify the allergenic 
molecules/sources that each patient has to avoid. 
However, the widespread diagnostic systems, based on the 
use of raw protein extracts, do not provide reliable 
responses. Nevertheless, recent studies indicate that 
allergy diagnosis can be improved by dealing with 
different aspects ranging from the choice of new 
methodologies to the accurate selection of reagents and of 
experimental conditions to be applied. So, in perspective, 
we could reach a more reliable allergy diagnosis if some 
new concepts and methodologies will be welcomed and 
applied. 
For instance, the new systems based on allergenic 
molecules will provide an increased reliability of the 
allergy testing results because the use of purified allergens 
allows a better standardization of the diagnostic tests. The 
multiplex biochip-based immunoassay (ISAC system) 
represents an additional improvement because it makes 
possible the analysis of the reactivity towards more than 
one hundred allergens with a single test, using only 20 l 
of serum. Furthermore, it allows the detection of 
unsuspected sensitivities caused by hidden allergens 
because no preselection of allergenic molecules to be 
tested is applied.  
Recent literature reports suggest that the inclusion in 
the diagnostic systems of a panel of homologous 
components from different sources, rather than one 
component chosen to represent all the homologs, will also 
contribute to the improvement in the accuracy of allergy 
diagnosis. In fact, the recent literature shows that 
homologous proteins, grouped in a single family on the 
basis of their biochemical features, can have different 
immunological properties, that means that “one allergen 
does not fit its homologs”. 
Additional improvements of both in vivo and in vitro 
allergy tests can be reached by exploiting the observation 
that the physico-chemical features of the experimental 
conditions used to make the test can affect the allergen 
properties, thus affecting the allergen-IgE interaction and 
therefore the response of the diagnostic test. 
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